Assessment of the status of inoperable cervical cancer patients treated in a selected hospital: a single-center, observational study

Shamsun Nahar; M. Saidul Haque; Rifat Zia Hossain; Afsana Sharmin Anika; Faruk  Ahmed; M. Harun Or Rashid; Taskin Dilshad

doi:10.18203/2320-6012.ijrms20260220

Authors

Shamsun Nahar Department of Clinical Oncology, Bangladesh Medical University, Dhaka, Bangladesh
M. Saidul Haque Department of Clinical Oncology, Bangladesh Medical University, Dhaka, Bangladesh
Rifat Zia Hossain Department of Clinical Oncology, Bangladesh Medical University, Dhaka, Bangladesh
Afsana Sharmin Anika Department of Clinical Oncology, Labaid Cancer Hospital and Super speciality Center, Dhaka, Bangladesh
Faruk Ahmed Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh
M. Harun Or Rashid Department of Clinical Oncology, Bangladesh Medical University, Dhaka, Bangladesh
Taskin Dilshad Department of Clinical Oncology, Bangladesh Medical University, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260220

Keywords:

Inoperable cervical cancer, Chemoradiation, Socio-demographic factors, Bangladesh, FIGO stage IIB-IVA

Abstract

Background: Cervical cancer remains a leading cause of cancer-related morbidity and mortality in low-resource settings. This study aimed to assess the socio-demographic and clinical characteristics of inoperable cervical cancer patients treated at a tertiary care hospital in Bangladesh.

Methods: A single-centered, observational study was conducted using retrospective data from patients diagnosed with inoperable cervical cancer. Patient demographics, tumor staging, histopathological features, and treatment modalities were analyzed. Statistical associations between variables were evaluated using chi-square and Fisher’s exact tests.

Results: The mean age of patients was 48.94 years, with 61.1% aged between 41 and 60. Over half (55.6%) were married at or before age 15, and 79.2% had three or more children. Most patients (83.3%) reported using oral contraceptives, and 23.6% had a family history of cancer. Stage IIB was the most common FIGO stage (52.8%), and squamous cell carcinoma (SCC) was the predominant histological type (73.6%). Tumor grade II was most frequent (73.6%). Standard chemoradiation was administered, including weekly cisplatin, external beam radiotherapy (EBRT) (mean dose 48.94 Gy), and intracavitary brachytherapy (80.6% received 21 Gy in three insertions). No significant associations were found between histopathological type (HPR) and stage (p=0.334) or family history and stage (p=1.000).

Conclusions: The study reveals a pattern of late-stage cervical cancer diagnosis in middle-aged women with identifiable socio-demographic risk factors. Strengthening early screening and awareness initiatives is critical to reducing the burden of inoperable cases in Bangladesh.

Metrics

Metrics Loading ...

References

Bray F, Laversanne M, Sung H. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63. DOI: https://doi.org/10.3322/caac.21834

World Health Organization. Cervical cancer: Key facts. 2024. Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed on 22 December 2025.

Hull R, Mbele M, Makhafola T. Cervical cancer in low and middle-income countries. Oncology Letters. 2020;20(3):2058-74. DOI: https://doi.org/10.3892/ol.2020.11754

Bruni L, Serrano B, Roura E. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. The Lancet Global Health. 2022;10(8):e1115-27. DOI: https://doi.org/10.1016/S2214-109X(22)00241-8

Abila DB, Wasukira SB, Ainembabazi P. Coverage and socioeconomic inequalities in cervical cancer screening in low- and middle-income countries between 2010 and 2019. JCO Global Oncol. 2024;10:e2300385. DOI: https://doi.org/10.1200/GO.23.00385

Dorji T, Nopsopon T, Tamang ST, Pongpirul K. Human papillomavirus vaccination uptake in low- and middle-income countries: a meta-analysis. E Clin Med. 2021;34:100836. DOI: https://doi.org/10.1016/j.eclinm.2021.100836

International Agency for Research on Cancer (IARC). Bangladesh: Cervical cancer fact sheet (GLOBOCAN 2023, v1.1). 2024. Available at: https://gco.iarc.who.int/media/globocan/factsheets/populations/50-bangladesh-fact-sheet.pdf. Accessed on 22 December 2025.

ICO/IARC HPV Information Centre. Bangladesh: Human papillomavirus and related cancers, fact sheet 2023. Available at: https://hpvcentre.net/statistics/reports/BGD.pdf. Accessed on 22 December 2025.

Reza S, Dewan SM, Islam MS, Shahriar M. Response of Bangladesh to the World Health Organization call to eliminate cervical cancer as a public health issue: An observational report. Health Sci Rep. 2024;7(6):e2178. DOI: https://doi.org/10.1002/hsr2.2178

Uddin AKM, Sumon MA, Pervin S, Sharmin F. Cervical cancer in Bangladesh. South Asian Journal of Cancer. 2023;12(1):36-8. DOI: https://doi.org/10.1055/s-0043-1764202

Nessa A, Azad AK, Uddin SM, Khan MA, Zaman S, Khan MA. Cervical cancer screening data from the case-based national electronic registry in Bangladesh. BMC Global and Public Health. 2025;3(1):34. DOI: https://doi.org/10.1186/s44263-025-00145-x

Devarapalli P, Labani S, Nagarjuna N, Panchal P, Asthana S. Barriers affecting uptake of cervical cancer screening in low and middle income countries: a systematic review. Indian J Cancer. 2018;55(4):318-26. DOI: https://doi.org/10.4103/ijc.IJC_253_18

Bhatla N, Berek JS, Cuello FM. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet. 2019;145(1):129-35. DOI: https://doi.org/10.1002/ijgo.12749

Chase DM, Huang HQ, Wenzel L. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecologic Oncol. 2012;125(2):315-9. DOI: https://doi.org/10.1016/j.ygyno.2012.01.047

Mallica M, Abdullah-Al-Noman M, Hoque H, Mahmud T. Clinicopathological profile of cervical cancer patients attending at tertiary level hospital in Dhaka, Bangladesh. South Asian J Cancer. 2024;13(1):51-8.

Thulaseedharan JV, Malila N, Hakama M. Socio demographic and reproductive risk factors for cervical cancer-a large prospective cohort study from rural India. Asian Pacific J Cancer Prevention. 2012;13(6):2991-5. DOI: https://doi.org/10.7314/APJCP.2012.13.6.2991

Sanjose LN. Exploring the nexus between young marriage and cervical cancer incidence. Int J Nursing Midwifery Res. 2024;2(2):70-7. DOI: https://doi.org/10.35335/ners.v2i2.261

Ndejjo R, Mukama T, Kiguli J, Musoke D. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: A qualitative study. BMJ Open. 2017;7(6):e016282. DOI: https://doi.org/10.1136/bmjopen-2017-016282

Moosazadeh M, Karimi A, Zaboli E, Hedayatizadeh-Omran A, Reza A, Kheradmand M. Risk of ovarian and cervical cancer in women with positive cancer family history: Results of Tabari cohort study. Clin Cancer Investigat J. 2021;10(2):65-8. DOI: https://doi.org/10.51847/bb522g3l7c891

Negri E, La Vecchia C, Bosetti C, Franceschi S, Parazzini F. Risk of cervical cancer in women with a family history of breast and female genital tract neoplasms. Int J Cancer. 2005;117(5):880-1. DOI: https://doi.org/10.1002/ijc.21211

Anggraeni TD. Distribution of age, stage, and histopathology of cervical cancer: A retrospective study on patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia, 2006-2010. Indonesian J Obstet Gynecol. 2011;35(1):21-4.

Yang L, Jia X, Li N, Chen C, Liu Y, Wang H. Comprehensive clinic-pathological characteristics of cervical cancer in southwestern China and the clinical significance of histological type and lymph node metastases in young patients. PLoS ONE. 2013;8(10):e75849. DOI: https://doi.org/10.1371/journal.pone.0075849

Ye Y, Zhang G, Li Z. Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14‐year multicenter study. Cancer Medicine. 2023;12(19):19617-32. DOI: https://doi.org/10.1002/cam4.6586

Teke F, Yoney A, Teke M. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Asian Pacific J Cancer Prevent. 2014;15(6):2415-8. DOI: https://doi.org/10.7314/APJCP.2014.15.6.2815

Liang C, Su G, Sun L, Zhao H, Liu P, Chen C. Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score‐matched real‐world analysis. Int J Gynecol Obstet. 2024;166(1):272-81. DOI: https://doi.org/10.1002/ijgo.15388

World Health Organization. Comprehensive cervical cancer control: A guide to essential practice (2nded.). 2014. Available at: https://apps.who.int/iris/handle/10665/144785. Accessed on 22 December 2025.

Gupta IJ, Ghosh A, Yadav J. External Beam Radiotherapy Interdigitated with High Dose Rate (HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix–Randomized Control Study. Asian Pacific J Cancer Prevent. 2023;24(10):3441. DOI: https://doi.org/10.31557/APJCP.2023.24.10.3441

Ryu SY, Lee WM, Kim K. Randomized Clinical Trial of Weekly vs. Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Physics. 2011;81(4):e577-81. DOI: https://doi.org/10.1016/j.ijrobp.2011.05.002

Bellinger JD, Brandt HM, Hardin JW, Bynum SA, Sharpe PA, Jackson D. The role of family history of cancer on cervical cancer screening behavior in a population-based survey of women in the Southeastern United States. Women’s Health Issues. 2013;23(4):e197-204. DOI: https://doi.org/10.1016/j.whi.2013.03.003